APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Omeprazole

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Omeprazole Industry Growth and Trends Forecast to 2032

Report ID 174018810120 December 2025104 pages

Choose your research edition.

Industry ResearchOmeprazole Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Omeprazole Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Omeprazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omeprazole Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Omeprazole Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Omeprazole market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Omeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Omeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omeprazole is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Omeprazole include Teva, Sandoz, Mylan, AstraZeneca AB, Stada, Saval Pharmaceutical, Sanofi, Mepha, KernPharm and Garmish Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Omeprazole market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Omeprazole market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Omeprazole market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Omeprazole.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Omeprazole market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Omeprazole Market by Company

Teva

Sandoz

Mylan

AstraZeneca AB

Stada

Saval Pharmaceutical

Sanofi, Mepha

KernPharm

Garmish Pharmaceuticals

CQ Lummy

Blaskov

Actavis

Omeprazole Segment by Type

Injection

Tablet

Capsule

Omeprazole Segment by Application

Children

Adult

Omeprazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omeprazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omeprazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omeprazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Omeprazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Omeprazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Tablet Table 3. Major Company of Capsule Table 4. Global Omeprazole Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Omeprazole Sales by Type (2021-2026) & (tons) Table 6. Global Omeprazole Sales Market Share in Volume by Type (2021-2026) Table 7. Global Omeprazole Sales by Type (2021-2026) & (US$ Million) Table 8. Global Omeprazole Sales Market Share in Value by Type (2021-2026) Table 9. Global Omeprazole Price by Type (2021-2026) & (US$/ton) Table 10. Global Omeprazole Sales by Type (2027-2032) & (tons) Table 11. Global Omeprazole Sales Market Share in Volume by Type (2027-2032) Table 12. Global Omeprazole Sales by Type (2027-2032) & (US$ Million) Table 13. Global Omeprazole Sales Market Share in Value by Type (2027-2032) Table 14. Global Omeprazole Price by Type (2027-2032) & (US$/ton) Table 15. North America Omeprazole Sales by Type (2021-2026) & (tons) Table 16. North America Omeprazole Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Omeprazole Sales by Type (2021-2026) & (tons) Table 18. Europe Omeprazole Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Omeprazole Sales by Type (2021-2026) & (tons) Table 20. Asia-Pacific Omeprazole Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Omeprazole Sales by Type (2021-2026) & (tons) Table 22. Latin America Omeprazole Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Omeprazole Sales by Type (2021-2026) & (tons) Table 24. Middle East and Africa Omeprazole Sales by Type (2021-2026) & (US$ Million) Table 25. Omeprazole Industry Trends Table 26. Omeprazole Industry Drivers Table 27. Omeprazole Industry Opportunities and Challenges Table 28. Omeprazole Industry Restraints Table 29. Global Omeprazole Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Omeprazole Revenue Market Share by Company (2021-2026) Table 31. Global Omeprazole Sales by Company (2021-2026) & (tons) Table 32. Global Omeprazole Sales Share by Company (2021-2026) Table 33. Global Omeprazole Market Price by Company (2021-2026) & (US$/ton) Table 34. Global Omeprazole Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Omeprazole Major Company Production Sites and Headquarters Table 36. Global Omeprazole Company, Product Type & Application Table 37. Global Omeprazole Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Omeprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Omeprazole Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Omeprazole Sales by Region (2021-2026) & (tons) Table 42. Global Omeprazole Sales Market Share in Volume by Region (2021-2026) Table 43. Global Omeprazole Sales by Region (2021-2026) & (US$ Million) Table 44. Global Omeprazole Sales Market Share in Value by Region (2021-2026) Table 45. Global Omeprazole Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Global Omeprazole Sales by Region (2027-2032) & (tons) Table 47. Global Omeprazole Sales Market Share in Volume by Region (2027-2032) Table 48. Global Omeprazole Sales by Region (2027-2032) & (US$ Million) Table 49. Global Omeprazole Sales Market Share in Value by Region (2027-2032) Table 50. Global Omeprazole Sales (tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 51. Global Omeprazole Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Omeprazole Sales by Application (2021-2026) & (tons) Table 53. Global Omeprazole Sales Market Share in Volume by Application (2021-2026) Table 54. Global Omeprazole Sales by Application (2021-2026) & (US$ Million) Table 55. Global Omeprazole Sales Market Share in Value by Application (2021-2026) Table 56. Global Omeprazole Price by Application (2021-2026) & (US$/ton) Table 57. Global Omeprazole Sales by Application (2027-2032) & (tons) Table 58. Global Omeprazole Sales Market Share in Volume by Application (2027-2032) Table 59. Global Omeprazole Sales by Application (2027-2032) & (US$ Million) Table 60. Global Omeprazole Sales Market Share in Value by Application (2027-2032) Table 61. Global Omeprazole Price by Application (2027-2032) & (US$/ton) Table 62. North America Omeprazole Sales by Application (2021-2026) & (tons) Table 63. North America Omeprazole Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Omeprazole Sales by Application (2021-2026) & (tons) Table 65. Europe Omeprazole Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Omeprazole Sales by Application (2021-2026) & (tons) Table 67. Asia-Pacific Omeprazole Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Omeprazole Sales by Application (2021-2026) & (tons) Table 69. Latin America Omeprazole Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Omeprazole Sales by Application (2021-2026) & (tons) Table 71. Middle East and Africa Omeprazole Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. Teva Omeprazole Product Portfolio Table 76. Teva Recent Development Table 77. Sandoz Company Information Table 78. Sandoz Business Overview Table 79. Sandoz Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Sandoz Omeprazole Product Portfolio Table 81. Sandoz Recent Development Table 82. Mylan Company Information Table 83. Mylan Business Overview Table 84. Mylan Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. Mylan Omeprazole Product Portfolio Table 86. Mylan Recent Development Table 87. AstraZeneca AB Company Information Table 88. AstraZeneca AB Business Overview Table 89. AstraZeneca AB Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. AstraZeneca AB Omeprazole Product Portfolio Table 91. AstraZeneca AB Recent Development Table 92. Stada Company Information Table 93. Stada Business Overview Table 94. Stada Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Stada Omeprazole Product Portfolio Table 96. Stada Recent Development Table 97. Saval Pharmaceutical Company Information Table 98. Saval Pharmaceutical Business Overview Table 99. Saval Pharmaceutical Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Saval Pharmaceutical Omeprazole Product Portfolio Table 101. Saval Pharmaceutical Recent Development Table 102. Sanofi, Mepha Company Information Table 103. Sanofi, Mepha Business Overview Table 104. Sanofi, Mepha Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Sanofi, Mepha Omeprazole Product Portfolio Table 106. Sanofi, Mepha Recent Development Table 107. KernPharm Company Information Table 108. KernPharm Business Overview Table 109. KernPharm Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. KernPharm Omeprazole Product Portfolio Table 111. KernPharm Recent Development Table 112. Garmish Pharmaceuticals Company Information Table 113. Garmish Pharmaceuticals Business Overview Table 114. Garmish Pharmaceuticals Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 115. Garmish Pharmaceuticals Omeprazole Product Portfolio Table 116. Garmish Pharmaceuticals Recent Development Table 117. CQ Lummy Company Information Table 118. CQ Lummy Business Overview Table 119. CQ Lummy Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 120. CQ Lummy Omeprazole Product Portfolio Table 121. CQ Lummy Recent Development Table 122. Blaskov Company Information Table 123. Blaskov Business Overview Table 124. Blaskov Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 125. Blaskov Omeprazole Product Portfolio Table 126. Blaskov Recent Development Table 127. Actavis Company Information Table 128. Actavis Business Overview Table 129. Actavis Omeprazole Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 130. Actavis Omeprazole Product Portfolio Table 131. Actavis Recent Development Table 132. North America Omeprazole Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 133. North America Omeprazole Sales by Country (2021-2026) & (tons) Table 134. North America Omeprazole Sales Market Share by Country (2021-2026) Table 135. North America Omeprazole Sales Forecast by Country (2027-2032) & (tons) Table 136. North America Omeprazole Sales Market Share Forecast by Country (2027-2032) Table 137. North America Omeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Omeprazole Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Omeprazole Market Share by Country (2021-2026) Table 140. North America Omeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Omeprazole Market Share Forecast by Country (2027-2032) Table 142. Europe Omeprazole Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 143. Europe Omeprazole Sales by Country (2021-2026) & (tons) Table 144. Europe Omeprazole Sales Market Share by Country (2021-2026) Table 145. Europe Omeprazole Sales Forecast by Country (2027-2032) & (tons) Table 146. Europe Omeprazole Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Omeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Omeprazole Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Omeprazole Market Share by Country (2021-2026) Table 150. Europe Omeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Omeprazole Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Omeprazole Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Omeprazole Sales by Country (2021-2026) & (tons) Table 154. Asia-Pacific Omeprazole Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Omeprazole Sales Forecast by Country (2027-2032) & (tons) Table 156. Asia-Pacific Omeprazole Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Omeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Omeprazole Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Omeprazole Market Share by Country (2021-2026) Table 160. Asia-Pacific Omeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Omeprazole Market Share Forecast by Country (2027-2032) Table 162. Latin America Omeprazole Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 163. Latin America Omeprazole Sales by Country (2021-2026) & (tons) Table 164. Latin America Omeprazole Sales Market Share by Country (2021-2026) Table 165. Latin America Omeprazole Sales Forecast by Country (2027-2032) & (tons) Table 166. Latin America Omeprazole Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Omeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Omeprazole Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Omeprazole Market Share by Country (2021-2026) Table 170. Latin America Omeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Omeprazole Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Omeprazole Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Omeprazole Sales by Country (2021-2026) & (tons) Table 174. Middle East and Africa Omeprazole Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Omeprazole Sales Forecast by Country (2027-2032) & (tons) Table 176. Middle East and Africa Omeprazole Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Omeprazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Omeprazole Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Omeprazole Market Share by Country (2021-2026) Table 180. Middle East and Africa Omeprazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Omeprazole Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Omeprazole Distributors List Table 185. Omeprazole Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Omeprazole Image Figure 2. Global Omeprazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omeprazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Omeprazole Sales (2021-2032) & (tons) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (tons) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (tons) Figure 9. Capsule Image Figure 10. Global Capsule Sales YoY Growth (2021-2032) & (tons) Figure 11. Global Omeprazole Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Omeprazole Market Share by Type 2025 VS 2032 Figure 13. North America Omeprazole Sales Market Share in Volume by Type in 2025 Figure 14. North America Omeprazole Sales Market Share in Value by Type in 2025 Figure 15. Europe Omeprazole Sales Market Share in Volume by Type in 2025 Figure 16. Europe Omeprazole Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Omeprazole Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Omeprazole Sales Market Share in Value by Type in 2025 Figure 19. Latin America Omeprazole Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Omeprazole Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Omeprazole Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Omeprazole Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Omeprazole Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Children Image Figure 26. Global Children Sales YoY Growth (2021-2032) & (tons) Figure 27. Adult Image Figure 28. Global Adult Sales YoY Growth (2021-2032) & (tons) Figure 29. Global Omeprazole Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Omeprazole Market Share by Application 2025 VS 2032 Figure 31. North America Omeprazole Sales Market Share in Volume by Application in 2025 Figure 32. North America Omeprazole Sales Market Share in Value by Application in 2025 Figure 33. Europe Omeprazole Sales Market Share in Volume by Application in 2025 Figure 34. Europe Omeprazole Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Omeprazole Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Omeprazole Sales Market Share in Value by Application in 2025 Figure 37. Latin America Omeprazole Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Omeprazole Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Omeprazole Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Omeprazole Sales Market Share in Value by Application in 2025 Figure 41. North America Omeprazole Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 42. North America Omeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Omeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Omeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Omeprazole Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 46. Europe Omeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Omeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Omeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Omeprazole Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 50. Asia-Pacific Omeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Omeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Omeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Omeprazole Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 54. Latin America Omeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Omeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Omeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Omeprazole Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 58. Middle East and Africa Omeprazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Omeprazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Omeprazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Omeprazole Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Omeprazole Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Capsule
Applications
  • Children
  • Adult
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • AstraZeneca AB
  • Stada
  • Saval Pharmaceutical
  • Sanofi, Mepha
  • KernPharm
  • Garmish Pharmaceuticals
  • CQ Lummy
  • Blaskov
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Omeprazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Omeprazole Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Omeprazole Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Tablet
  8. 1.3.3 Capsule
  9. 1.4 Global Omeprazole Market Size by Type
  10. 1.4.1 Global Omeprazole Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Omeprazole Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Omeprazole Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Omeprazole Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Omeprazole Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Omeprazole Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Omeprazole Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Omeprazole Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Omeprazole Industry Trends
  2. 2.2 Omeprazole Industry Drivers
  3. 2.3 Omeprazole Industry Opportunities and Challenges
  4. 2.4 Omeprazole Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Omeprazole Revenue (2021-2026)
  2. 3.2 Global Top Players by Omeprazole Sales (2021-2026)
  3. 3.3 Global Top Players by Omeprazole Price (2021-2026)
  4. 3.4 Global Omeprazole Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Omeprazole Major Company Production Sites & Headquarters
  6. 3.6 Global Omeprazole Company, Product Type & Application
  7. 3.7 Global Omeprazole Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Omeprazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Omeprazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Omeprazole Tier 1, Tier 2, and Tier 3
4 Omeprazole Regional Status and Outlook
  1. 4.1 Global Omeprazole Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Omeprazole Historic Market Size by Region
  3. 4.2.1 Global Omeprazole Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Omeprazole Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Omeprazole Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Omeprazole Forecasted Market Size by Region
  7. 4.3.1 Global Omeprazole Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Omeprazole Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Omeprazole Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Omeprazole by Application
  1. 5.1 Omeprazole Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Omeprazole Market Size by Application
  5. 5.2.1 Global Omeprazole Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Omeprazole Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Omeprazole Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Omeprazole Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Omeprazole Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Omeprazole Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Omeprazole Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Omeprazole Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Omeprazole Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Omeprazole Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Omeprazole Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 AstraZeneca AB
  20. 6.4.1 AstraZeneca AB Company Information
  21. 6.4.2 AstraZeneca AB Business Overview
  22. 6.4.3 AstraZeneca AB Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AstraZeneca AB Omeprazole Product Portfolio
  24. 6.4.5 AstraZeneca AB Recent Developments
  25. 6.5 Stada
  26. 6.5.1 Stada Company Information
  27. 6.5.2 Stada Business Overview
  28. 6.5.3 Stada Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Stada Omeprazole Product Portfolio
  30. 6.5.5 Stada Recent Developments
  31. 6.6 Saval Pharmaceutical
  32. 6.6.1 Saval Pharmaceutical Company Information
  33. 6.6.2 Saval Pharmaceutical Business Overview
  34. 6.6.3 Saval Pharmaceutical Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Saval Pharmaceutical Omeprazole Product Portfolio
  36. 6.6.5 Saval Pharmaceutical Recent Developments
  37. 6.7 Sanofi, Mepha
  38. 6.7.1 Sanofi, Mepha Company Information
  39. 6.7.2 Sanofi, Mepha Business Overview
  40. 6.7.3 Sanofi, Mepha Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi, Mepha Omeprazole Product Portfolio
  42. 6.7.5 Sanofi, Mepha Recent Developments
  43. 6.8 KernPharm
  44. 6.8.1 KernPharm Company Information
  45. 6.8.2 KernPharm Business Overview
  46. 6.8.3 KernPharm Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 KernPharm Omeprazole Product Portfolio
  48. 6.8.5 KernPharm Recent Developments
  49. 6.9 Garmish Pharmaceuticals
  50. 6.9.1 Garmish Pharmaceuticals Company Information
  51. 6.9.2 Garmish Pharmaceuticals Business Overview
  52. 6.9.3 Garmish Pharmaceuticals Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Garmish Pharmaceuticals Omeprazole Product Portfolio
  54. 6.9.5 Garmish Pharmaceuticals Recent Developments
  55. 6.10 CQ Lummy
  56. 6.10.1 CQ Lummy Company Information
  57. 6.10.2 CQ Lummy Business Overview
  58. 6.10.3 CQ Lummy Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CQ Lummy Omeprazole Product Portfolio
  60. 6.10.5 CQ Lummy Recent Developments
  61. 6.11 Blaskov
  62. 6.11.1 Blaskov Company Information
  63. 6.11.2 Blaskov Business Overview
  64. 6.11.3 Blaskov Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Blaskov Omeprazole Product Portfolio
  66. 6.11.5 Blaskov Recent Developments
  67. 6.12 Actavis
  68. 6.12.1 Actavis Company Information
  69. 6.12.2 Actavis Business Overview
  70. 6.12.3 Actavis Omeprazole Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Actavis Omeprazole Product Portfolio
  72. 6.12.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Omeprazole Sales by Country
  2. 7.1.1 North America Omeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Omeprazole Sales by Country (2021-2026)
  4. 7.1.3 North America Omeprazole Sales Forecast by Country (2027-2032)
  5. 7.2 North America Omeprazole Market Size by Country
  6. 7.2.1 North America Omeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Omeprazole Market Size by Country (2021-2026)
  8. 7.2.3 North America Omeprazole Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Omeprazole Sales by Country
  2. 8.1.1 Europe Omeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Omeprazole Sales by Country (2021-2026)
  4. 8.1.3 Europe Omeprazole Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Omeprazole Market Size by Country
  6. 8.2.1 Europe Omeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Omeprazole Market Size by Country (2021-2026)
  8. 8.2.3 Europe Omeprazole Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Omeprazole Sales by Country
  2. 9.1.1 Asia-Pacific Omeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Omeprazole Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Omeprazole Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Omeprazole Market Size by Country
  6. 9.2.1 Asia-Pacific Omeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Omeprazole Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Omeprazole Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Omeprazole Sales by Country
  2. 10.1.1 South America Omeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Omeprazole Sales by Country (2021-2026)
  4. 10.1.3 South America Omeprazole Sales Forecast by Country (2027-2032)
  5. 10.2 South America Omeprazole Market Size by Country
  6. 10.2.1 South America Omeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Omeprazole Market Size by Country (2021-2026)
  8. 10.2.3 South America Omeprazole Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Omeprazole Sales by Country
  2. 11.1.1 Middle East and Africa Omeprazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Omeprazole Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Omeprazole Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Omeprazole Market Size by Country
  6. 11.2.1 Middle East and Africa Omeprazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Omeprazole Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Omeprazole Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Omeprazole Value Chain Analysis
  2. 12.1.1 Omeprazole Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Omeprazole Production Mode & Process
  7. 12.2 Omeprazole Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Omeprazole Distributors
  10. 12.2.3 Omeprazole Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst